Routine officer appointment with no stock-moving implications. Monitor for potential transition to full-time employment or changes in engagement level, but no immediate trading catalyst.
Price Chart
Executive Summary
BiomX Inc. appointed Roy Rousso as Chief Business Officer (and, per the consulting agreement, COO/CBO) effective July 1, 2026, via a consulting agreement with $11,900/month base compensation at a 70% engagement level, plus eligibility for an annual performance bonus of up to $71,400 and a 200,000-share equity grant vesting over three years. This is a routine officer appointment with no material financial data or strategic changes disclosed, and no departures were announced.
Key Facts
- Appointed Roy Rousso as Chief Business Officer effective July 1, 2026
- Consulting agreement: $11,900/month base fee (70% of full-time $17,000/month)
- Annual performance bonus up to 50% of base fee (up to $71,400 per annum at 70% engagement)
- Equity grant of 200,000 shares of common stock, vesting in 3 equal annual installments
- 12-month post-termination non-compete and non-solicitation covenants
- Part-time independent contractor arrangement; parties intend to transition to full-time salaried employment as business develops
Financial Impact
Annual cash compensation of approximately $142,800 in base fee plus up to $71,400 bonus potential at current engagement level; 200,000 share equity award with three-year vesting
Risk Factors
- Part-time engagement may limit bandwidth relative to a full-time COO/CBO
- Equity grant adds modest shareholder dilution (~200K shares vs $16M market cap)
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-061772 |
| Document: ea0292479-8k_biomx.htm | 0001213900-26-061772 |
| Document: 0001213900-26-061772-index-headers.html | 0001213900-26-061772 |
| Document: 0001213900-26-061772-index.html | 0001213900-26-061772 |
| Document: 0001213900-26-061772.txt | 0001213900-26-061772 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 1, 2026 4w ago | 8-K | $0.1425 $1.85 | ▲ +1198.25% | ▲ +1199.20% | $0.3600 (+152.63%) |
Aug 28, 2026 5w ago | 8-K | $0.1371 $0.1550 | ▲ +13.06% | ▲ +13.20% | $0.3600 (+162.58%) |
Aug 5, 2026 8w ago | Press Release | $0.1800 $0.1483 | ▲ +17.61% | ▲ +17.96% | $0.3600 (−100.00%) |
Jul 28, 2026 9w ago | 8-K | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 28, 2026 9w ago | Press Release | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 27, 2026 9w ago | 424B5 | $0.1834 $0.1868 | ▼ −1.85% | ▲ +0.42% | $0.3600 (−96.29%) |
Jul 8, 2026 12w ago | Press Release | $0.2758 $0.2100 | ▼ −23.86% | ▼ −24.72% | $0.3600 (+30.53%) |
Jul 2, 2026 13w ago | 8-K | $0.3190 $0.2800 | ▲ +12.23% | ▲ +13.16% | $0.3600 (−12.85%) |
Jun 29, 2026 13w ago | S-1 | $0.3478 $0.3020 | ▲ +13.17% | ▲ +13.77% | $0.3600 (−3.51%) |
Jun 22, 2026 14w ago | DEFA14A | $0.4615 $0.3590 | ▼ −22.21% | ▼ −23.22% | $0.3600 (−21.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access